Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Effects of dietary changes on food choices and brain function

Official title: "SFB 1052/3 - Mechanismen Der Adipositas, Projekt A1: Veränderung Der Neurobiologischen Grundlagen Von Ess-Entscheidungen Bei Adipositas" Engl. "CRC 1052/3 - Obesity Mechanisms, Project A1: Targeting Neurobehavioral Determinants of Obesity"

Run by Max Planck Institute for Human Cognitive and Brain Sciences · NCT05353504 · Data updated 2026-11-12

This study is testing if changing diets can help overweight and obese adults make better food choices and improve their brain function.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment90 (estimated)
SponsorMax Planck Institute for Human Cognitive and Brain Sciences
Academic / other
Locations1 site (Leipzig)
StatusRecruiting
StartedMarch 8, 2022
Main results expectedDecember 2024
Study endsDecember 2026
Registry record updatedApril 29, 2022
Trial IDNCT05353504 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are overweight or obese adults with a BMI of 25 kg/m2 or higher.

Probably not a fit

Patients with clinically relevant psychiatric diseases, chronic inflammatory or malignant diseases, or those who have undergone bariatric surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates how dietary interventions that alter the gut microbiome can influence food decision-making in overweight and obese adults. A total of 90 participants will be randomly assigned to receive either a pre-biotic dietary intervention, a behavioral lifestyle intervention, or a control condition over 26 weeks. The study will utilize functional and structural MRI, cognitive testing, and microbiota analysis through stool samples to assess changes in brain function and gut health. The goal is to understand the mechanisms behind how diet impacts food choices and overall health.

Why it matters

Potential benefit: If successful, this study could lead to new dietary strategies that improve food decision-making and aid in weight management for individuals with obesity.

How similar studies have gone: While the specific approach of this study may be novel, previous research has shown promising results in the relationship between gut microbiota and dietary interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI \>= 25 kg/m2 or WHR \>= 0.9/0.85 (m/d, f)
* no MRI contra-indication
* written informed consent

Exclusion Criteria:

* athletes
* occurrence of a clinically relevant psychiatric disease in the last 12 months, e.g. depression, substance abuse, eating disorders, schizophrenia
* any chronic inflammatory or malignant disease
* type 1 diabetes
* previous bariatric/gastric surgery
* pregnancy or breastfeeding woman

Where it's running

  • Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences
    Leipzig, Germany
    Recruiting

Study contacts

  • Principal investigator: Veronica Witte, PhD — Cognitive Neurology, University Medical Center Leipzig
  • Study coordinator: Meghedi Vartanian, MSc
  • Email: mi-food@cbs.mpg.de
  • Phone: +49(0)341/9940-951

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.